Cargando…
The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature
Background: MALAT-1 is significantly overexpressed in various cancers, suggesting that it might be a potential biomarker of cancer. Methods: A meta-analysis was performed using microarray data obtained via the Affymetrix Human Genome U133 Plus 2.0 platform found in the Gene Expression Omnibus (GEO)...
Autores principales: | Wang, Yumin, Xue, Dan, Li, Yuwei, Pan, Xuya, Zhang, Xueying, Kuang, Biao, Zhou, Ming, Li, Xiaoling, Xiong, Wei, Li, Guiyuan, Zeng, Zhaoyang, Yang, Tubao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910592/ https://www.ncbi.nlm.nih.gov/pubmed/27313790 http://dx.doi.org/10.7150/jca.14663 |
Ejemplares similares
-
Long non-coding RNA AFAP1-AS1 is a novel biomarker in various cancers: a systematic review and meta-analysis based on the literature and GEO datasets
por: Wang, Yumin, et al.
Publicado: (2017) -
Upregulation of Long Noncoding RNA MALAT1 in Colorectal Cancer Promotes Radioresistance and Aggressive Malignance
por: Shen, Wenqi, et al.
Publicado: (2022) -
Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases
por: Xie, Zu-cheng, et al.
Publicado: (2017) -
Prognostic significance of MALAT1 in clear cell renal cell carcinoma based on TCGA and GEO
por: Liu, Kai, et al.
Publicado: (2023) -
Proteomic Analysis of the Molecular Mechanism of Lovastatin Inhibiting the Growth of Nasopharyngeal Carcinoma Cells
por: Mo, Yongzhen, et al.
Publicado: (2019)